Nira Medical and the Rocky Mountain Multiple Sclerosis Clinic (RMMSC) today announced the presentation of a joint research ...
A major UK study has revealed that the early warning signs of multiple sclerosis (MS)—including pain, mood changes, and ...
Join the School of Medicine’s Department of Population and Quantitative Health Sciences to learn about the options available with an MS in clinical research. A webinar will be held Sunday, Dec. 20, at ...
Late-breaking clinical data presented at the 41st Congress of the European Committee for Treatment and Research in Multiple SclerosisAcross non-active progressive MS (primary progressive and secondary ...
Higher intake of ultra-processed foods (UPFs) may exacerbate disease activity in early multiple sclerosis (MS), according to ...
A new version of the McDonald criteria — the official guidelines used to diagnose MS — aim to make MS diagnosis faster and ...
New research presented at the 41st Congress of the European Committee for Treatment and Research in Multiple Sclerosis ...
Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) ('Tiziana” or the 'Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal ...
Providing evidence for a new online MS assessment tool, researchers discovered the overlooked subtype in patients of all ages ...
Panelists discuss how diverse clinical trial data help build patient trust by demonstrating therapy effectiveness in similar populations and address barriers like health care mistrust and ...
The School of Medicine’s Department of Population and Quantitative Health Sciences will host a webinar presentation for members of the community to learn more about an MS in clinical research degree.